{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:02:50Z","timestamp":1767211370520,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL151984","HL068835"],"award-info":[{"award-number":["R01HL151984","HL068835"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000121","name":"National Science Foundation Division of Mathematical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000121","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jtha.2024.10.028","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T12:32:24Z","timestamp":1731414744000},"page":"480-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Examining downstream effects of concizumab in hemophilia A\u00a0with a mathematical modeling approach"],"prefix":"10.1016","volume":"23","author":[{"given":"Kenji","family":"Miyazawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan E.","family":"Mast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam R.","family":"Wufsus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Dockal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Kjalke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-1305","authenticated-orcid":false,"given":"Karin","family":"Leiderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.10.028_bib1","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Factor IX and Rare Coagulation Disorders of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis. Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.028_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1538-7836.2008.03270.x","article-title":"Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A","volume":"7","author":"Collins","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.028_bib3","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1182\/blood-2004-05-2008","article-title":"Thirty years of hemophilia treatment in the Netherlands, 1972-2001","volume":"104","author":"Plug","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.028_bib4","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-01-528414","article-title":"Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens","volume":"125","author":"Oldenburg","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.028_bib5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2516.2011.02539.x","article-title":"Clinical severity of haemophilia A: does the classification of the 1950s still stand?","volume":"17","author":"Den Uijl","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.10.028_bib6","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1182\/blood-2012-05-423210","article-title":"The gene therapy journey for hemophilia: are we there yet?","volume":"120","author":"High","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.028_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41587-020-0741-7","article-title":"A\u00a0long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells","volume":"39","author":"Nguyen","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtha.2024.10.028_bib8","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/jth.14296","article-title":"The future of bypassing agents for hemophilia with inhibitors in the era of novel agents","volume":"16","author":"Shapiro","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.028_bib9","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1182\/blood.2019001542","article-title":"Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A\/B with inhibitors: phase 2 trial results","volume":"134","author":"Shapiro","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.028_bib10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJMoa2216455","article-title":"Phase 3 trial of concizumab in hemophilia with inhibitors","volume":"389","author":"Matsushita","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.10.028_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/ATVBAHA.115.305996","article-title":"Tissue factor pathway inhibitor: multiple anticoagulant activities for a single protein","volume":"36","author":"Mast","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.10.028_bib12","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1182\/blood-2012-01-401620","article-title":"Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model","volume":"119","author":"Hilden","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.028_bib13","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.thromres.2012.02.030","article-title":"Hemostatic properties of a TFPI antibody","volume":"129","author":"Petersen","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.10.028_bib14","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1074\/jbc.273.8.4378","article-title":"Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor","volume":"273","author":"Baugh","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.10.028_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/CIRCULATIONAHA.113.003191","article-title":"Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein","volume":"128","author":"Schuijt","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.10.028_bib16","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1073\/pnas.1310444110","article-title":"Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation","volume":"110","author":"Wood","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.10.028_bib17","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016341","article-title":"Regulation of factor V and factor V-short by TFPI\u03b1: relationship between B-domain proteolysis and binding","volume":"296","author":"Petrillo","year":"2021","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.10.028_bib18","doi-asserted-by":"crossref","first-page":"9335","DOI":"10.1074\/jbc.M116.769570","article-title":"Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation","volume":"292","author":"Santamaria","year":"2017","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.10.028_bib19","doi-asserted-by":"crossref","first-page":"12686","DOI":"10.1021\/bi00208a020","article-title":"Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin","volume":"33","author":"Jesty","year":"1994","journal-title":"Biochemistry"},{"year":"2001","series-title":"The structure of a typical antibody molecule","author":"Janeway","key":"10.1016\/j.jtha.2024.10.028_bib20"},{"key":"10.1016\/j.jtha.2024.10.028_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bpj.2022.11.023","article-title":"Inhibition of platelet-surface-bound proteins during coagulation under flow I: TFPI","volume":"122","author":"Miyazawa","year":"2023","journal-title":"Biophys J"},{"key":"10.1016\/j.jtha.2024.10.028_bib22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bpj.2022.10.038","article-title":"Inhibition of platelet-surface-bound proteins during coagulation under flow II: antithrombin and heparin","volume":"122","author":"Miyazawa","year":"2023","journal-title":"Biophys J"},{"key":"10.1016\/j.jtha.2024.10.028_bib23","first-page":"551","article-title":"Heterogeneity of plasma tissue factor pathway inhibitor","volume":"5","author":"Broze","year":"1994","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2024.10.028_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0049-3848(97)00029-7","article-title":"Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in\u00a0vitro","volume":"85","author":"Hansen","year":"1997","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.10.028_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.thromres.2014.03.043","article-title":"Inhibitory effects of LDL-associated tissue factor pathway inhibitor","volume":"134","author":"Augustsson","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.10.028_bib26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/jth.14653","article-title":"A\u00a0mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A","volume":"18","author":"Link","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.028_bib27","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1182\/blood-2014-01-551812","article-title":"TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain","volume":"123","author":"Regli\u0144ska-Matveyev","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.028_bib28","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/jth.13665","article-title":"Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitor\u03b1, and protein S","volume":"15","author":"Dahlb\u00e4ck","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.028_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/ATVBAHA.113.302655","article-title":"Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-\u03b1 but not for cell surface\u2013associated tissue factor pathway inhibitor","volume":"34","author":"Wood","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.10.028_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/rth2.12057","article-title":"Factor V-short and protein S as synergistic tissue factor pathway inhibitor (TFPI\u03b1) cofactors","volume":"2","author":"Dahlb\u00e4ck","year":"2018","journal-title":"Res Pract Thromb Hsemost"},{"key":"10.1016\/j.jtha.2024.10.028_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/jth.15547","article-title":"The preAR2 region (1458\u20131492) in factor V-Short is crucial for the synergistic TFPI\u03b1-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPI\u03b1","volume":"20","author":"Dahlb\u00e4ck","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.028_bib32","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/jth.15690","article-title":"A\u00a0hydrophobic patch (PLVIVG; 1481\u20131486) in the B-domain of factor V-short is crucial for its synergistic TFPI\u03b1-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPI\u03b1, and protein S","volume":"20","author":"Dahlb\u00e4ck","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.028_bib33","first-page":"402","article-title":"Effect of concizumab on protein C activation and antithrombin activity","volume":"4","author":"Kjalke","year":"2020","journal-title":"Res Pract Thromb Hsemost"},{"key":"10.1016\/j.jtha.2024.10.028_bib34","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood-2013-11-512764","article-title":"Biology of tissue factor pathway inhibitor","volume":"123","author":"Wood","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.028_bib35","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1182\/bloodadvances.2017011098","article-title":"TFPI\u03b1 interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation","volume":"1","author":"Wood","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.10.028_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000089930","article-title":"Coagulation under flow: the influence of flow-mediated transport on the initiation and inhibition of coagulation","volume":"34","author":"Fogelson","year":"2005","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.jtha.2024.10.028_bib37","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0006-3495(01)76085-7","article-title":"Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition","volume":"80","author":"Kuharsky","year":"2001","journal-title":"Biophys J"},{"key":"10.1016\/j.jtha.2024.10.028_bib38","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1182\/blood-2007-08-106229","article-title":"Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow","volume":"111","author":"Okorie","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.028_bib39","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1161\/ATVBAHA.116.308186","article-title":"Synergy between tissue factor and exogenous factor XIa in initiating coagulation","volume":"36","author":"Leiderman","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.10.028_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078732","article-title":"The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational models","volume":"8","author":"Onasoga-Jarvis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2024.10.028_bib41","doi-asserted-by":"crossref","first-page":"17241","DOI":"10.1074\/jbc.M312827200","article-title":"Formation of factors IXa and Xa by the extrinsic pathway: differential regulation by tissue factor pathway inhibitor and antithrombin III","volume":"279","author":"Lu","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624006445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624006445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:12:38Z","timestamp":1762549958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624006445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1538783624006445"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.10.028","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining downstream effects of concizumab in hemophilia A\u00a0with a mathematical modeling approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}